Attention Deficit and Disruptive Behavior Disorders (Oppositional Defiant Disorder)

Also Known As:
Oppositional Defiant Disorder; Disruptive Behavior Disorder; Behavior Disorder, Disruptive; Defiant Disorder, Oppositional
Networked: 205 relevant articles (19 outcomes, 44 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
2. Conduct Disorder
3. Attention Deficit and Disruptive Behavior Disorders (Oppositional Defiant Disorder)
4. Mental Disorders (Mental Disorder)
5. Tic Disorders (Tic Disorder)


1. Gadow, Kenneth D: 10 articles (04/2015 - 06/2004)
2. Arnold, L Eugene: 7 articles (04/2015 - 10/2003)
3. Aman, Michael G: 7 articles (04/2015 - 01/2004)
4. Biederman, Joseph: 6 articles (05/2015 - 01/2003)
5. Masi, Gabriele: 6 articles (10/2013 - 12/2006)
6. Ghanizadeh, Ahmad: 6 articles (06/2011 - 01/2008)
7. Drabick, Deborah A G: 5 articles (12/2015 - 06/2004)
8. Faraone, Stephen V: 5 articles (05/2015 - 05/2006)
9. Findling, Robert L: 5 articles (04/2015 - 08/2006)
10. Yang, Li: 5 articles (01/2009 - 01/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Attention Deficit and Disruptive Behavior Disorders:
1. Risperidone (Risperdal Consta)FDA LinkGeneric
2. atomoxetine (Strattera)FDA LinkGeneric
3. Methylphenidate (Ritalin)FDA LinkGeneric
05/01/2011 - "This trial evaluated the effect of methylphenidate transdermal system (MTS) on the full spectrum of adult symptoms (attention-disorganization, hyperactivity-impulsivity, emotional dysregulation [ED], and oppositional-defiant disorder [ODD]) found in this disorder. "
05/01/2007 - "When compared with children with ADHD alone, children with comorbid anxiety or oppositional defiant disorder may show worsening of the global attention score in response to methylphenidate and not only a "reduced response," as reported in previous studies. "
05/01/2007 - "Children with ADHD and comorbid anxiety or oppositional defiant disorder might represent clinically distinct populations in which inattention is secondary to those disorders; therefore, methylphenidate may be an inappropriate treatment for such children."
07/01/2004 - "To test the hypotheses that in children with attention-deficit/hyperactivity disorder (ADHD) (1) symptoms of ADHD, oppositional defiant disorder, and overall functioning are significantly improved by methylphenidate combined with intensive multimodal psychosocial treatment compared with methylphenidate alone and with methylphenidate plus attention control and (2) more children receiving combined treatment can be taken off methylphenidate. "
02/01/2014 - "The aim of this study was to compare the effect of methylphenidate (MPH) versus MPH + parent training in children with ADHD and oppositional defiant disorder/conduct disorder (ODD/CD) over a 12-month period. "
4. quetiapine (Seroquel)FDA Link
5. aripiprazole (Abilify)FDA Link
6. ziprasidone (Geodon)FDA Link
7. pemetrexed (MTA)FDA Link
8. Clonidine (ST 155)FDA LinkGeneric
9. Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
10. Guanfacine (Tenex)FDA LinkGeneric

Therapies and Procedures

1. Combined Modality Therapy
2. Drug Therapy (Chemotherapy)
3. Play Therapy (Therapy, Play)
4. Polypharmacy
5. Speech Therapy (Therapy, Speech)